Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
19.00
+0.01 (0.05%)
Feb 5, 2026, 9:32 AM EST - Market open
Tandem Diabetes Care Analyst Ratings
Total Analysts
17
Consensus Rating
Buy
Price Target
$24.35
Upside
+28.16%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Hold Maintains $16 → $20 | Hold | Maintains | $16 → $20 | +5.26% | Feb 4, 2026 |
| Bernstein | Bernstein | Hold Maintains $18 → $25 | Hold | Maintains | $18 → $25 | +31.58% | Jan 9, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $17 → $24 | Hold | Maintains | $17 → $24 | +26.32% | Dec 18, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $24 → $35 | Strong Buy | Maintains | $24 → $35 | +84.21% | Dec 17, 2025 |
| Mizuho | Mizuho | Hold Maintains $18 → $21 | Hold | Maintains | $18 → $21 | +10.53% | Dec 17, 2025 |
| Baird | Baird | Hold → Buy Upgrades $18 → $30 | Hold → Buy | Upgrades | $18 → $30 | +57.89% | Dec 16, 2025 |
| Citigroup | Citigroup | Hold Maintains $16 → $22 | Hold | Maintains | $16 → $22 | +15.79% | Dec 11, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $17 → $23 | Hold | Maintains | $17 → $23 | +21.05% | Dec 2, 2025 |
| Barclays | Barclays | Buy Maintains $51 → $55 | Buy | Maintains | $51 → $55 | +189.47% | Nov 10, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $13 → $17 | Hold | Maintains | $13 → $17 | -10.53% | Nov 10, 2025 |
| Truist Securities | Truist Securities | Hold Reiterates $16 → $17 | Hold | Reiterates | $16 → $17 | -10.53% | Nov 10, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $13 → $14 | Hold | Maintains | $13 → $14 | -26.32% | Nov 7, 2025 |
| Stifel | Stifel | Hold Initiates $15 | Hold | Initiates | $15 | -21.05% | Oct 21, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $14 → $16 | Hold | Maintains | $14 → $16 | -15.79% | Oct 15, 2025 |
| Citigroup | Citigroup | Hold Maintains $11 → $15 | Hold | Maintains | $11 → $15 | -21.05% | Oct 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $24 | Strong Buy | Maintains | $24 | +26.32% | Sep 29, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.